EFFECTIVENESS OF EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT) IN THE MANAGEMENT OF SPASTICITY POST-STROKE: A CLINICAL EVALUATION

Main Article Content

Dr. Pawan Sharma
Dr. Sonu Singh
Dr. Maan Singh
Dr. Dwit Vora

Keywords

.

Abstract

Spasticity following stroke significantly impairs motor function and impacts quality of life. Current interventions, including pharmacological treatments, physical therapy, and surgical options, have demonstrated limited effectiveness and potential side effects. Extracorporeal shock wave therapy (ESWT) is gaining attention as a non-invasive option for spasticity management. This study assessed the efficacy of ESWT in reducing spasticity and enhancing motor function and quality of life in stroke survivors through a randomized controlled trial. Eighty participants were randomly assigned to receive either ESWT or standard care, with spasticity and motor function assessed using the Modified Ashworth Scale (MAS) and Fugl-Meyer Assessment (FMA), while quality of life was evaluated with the Stroke-Specific Quality of Life Scale (SSQOL). Post-treatment results showed significant spasticity reduction in the ESWT group, alongside notable improvements in motor function and quality of life. The findings suggest that ESWT is a viable, non-invasive option for enhancing spasticity management in stroke rehabilitation.

Abstract 41 | pdf Downloads 17

References

1. Lance JW. Pathophysiology of spasticity and clinical experience with baclofen. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: Disordered Motor Control. Chicago: Year Book Medical Publishers; 1980. p. 185-204.
2. Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities, and meaningful measurement. Disabil Rehabil. 2005;27(1-2):2-6.
3. Sommerfeld DK, Eek E, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35(1):134-9.
4. Opheim A, Danielsson A, Alt Murphy M, et al. Associations between upper extremity spasticity and activity limitations in poststroke patients. J Stroke Cerebrovasc Dis. 2014;23(9):2363-9.
5. Wu YT, Yu HK, Chen LR, et al. Extracorporeal shock wave therapy for spasticity in stroke patients: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(8):2470-6.
6. Amelio E, Manganotti P. Clinical application of shock wave therapy in stroke patients. Eur J Phys Rehabil Med. 2010;46(4):637-44.
7. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-7.
8. Bakheit AM, Thilmann AF, Ward AB, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to investigate the efficacy of botulinum toxin type A in the treatment of poststroke spasticity. Stroke. 2000;31(10):2402-6.
9. Baricich A, Picelli A, Santamato A, et al. Safety profile of botulinum toxin type A in post-stroke spasticity treatment: a systematic review. Toxins. 2021;13(8):561.
10. Esquenazi A. Upper limb spasticity: consequences and management. Clin Orthop Relat Res. 2002;(401):50-9.
11. Vahdatpour B, Vahdatpour B, Ahrar H, et al. Extracorporeal shock wave therapy in treatment of chronic plantar fasciitis; a randomized controlled trial. Orthop Traumatol Surg Res. 2009;95(8):495-500.
12. Hausner T, Pajenda G, Halder GE, et al. Effect of shock wave treatment on spasticity and motor function in a chronic stroke patient: a case study. Disabil Rehabil. 2012;34(5):419-23.
13. Chen TW, Lin CW, Lee CL, et al. Effect of extracorporeal shock wave therapy on muscle spasticity in children with cerebral palsy. Am J Phys Med Rehabil. 2020;99(9):813-8.
14. Santamato A, Panza F, Panza A, et al. Radial shock wave therapy for spasticity in patients affected by cerebral palsy or stroke. Eur J Phys Rehabil Med. 2014;50(4):451-7.
15. Wang C, Zhao J, Hu H, et al. The effects of extracorporeal shockwave therapy on upper limb spasticity and function in stroke patients: a meta-analysis. Front Neurol. 2020;11:847.
16. Bakheit AM, Fheodoroff K, Molteni F, et al. Spasticity in stroke patients. Epidemiology, implications, and management. 2005;27(10):1093-105.
17. Brainin M, Norrving B, Sunnerhagen KS, et al. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related comorbidities. Stroke. 2020;51(8):2447-55.
18. Marinov B, Mandos G. Overview of management strategies in poststroke spasticity. Phys Ther Rehabil. 2020;7:26.
19. Pinto CB, Alves M, Monteiro SC, et al. Botulinum toxin type A in poststroke spasticity. Curr Opin Neurol. 2022;35(1):104-12.
20. Wu YT, Yu HK, Chen LR, et al. Extracorporeal shock wave therapy for spasticity in stroke patients: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(8):2470-6.
21. Singh NK, Palekar TJ, Jayaram C, et al. Efficacy of extracorporeal shock wave therapy in managing spasticity in children with cerebral palsy. Int J Rehabil Res. 2018;41(2):140-5.
22. Hackett ML, Duncan JR, Anderson CS, et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2020;(7)
23. Koski L, Lebrun LH, White N, et al. Patient-focused stroke rehabilitation interventions. Neurorehabil Neural Repair. 2017;31(3):207-16.
24. Zou L, Yeung A, Li C, et al. Effects of mind-body exercises for poststroke spasticity: a systematic review and meta-analysis. PM&R. 2018;10(5):479-89.
25. Pavesi T, Hayes JM, Mendonca DA. Mechanisms of extracorporeal shockwave therapy in the management of post-stroke spasticity. Phys Ther Rehabil. 2020;7:22.
26. Tarnanen S, Rantanen P, Kautiainen H, et al. Assessment of spasticity after stroke. Clin Rehabil. 2016;30(9):804-12.
27. Wissel J, Ward AB, Erztgaard P, et al. European consensus on the concepts and measurement of spasticity. Clin Rehabil. 2010;24(2):148-60.